Market closed
Prime Medicine, Inc./$PRME
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Prime Medicine, Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Ticker
$PRME
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
214
Website
PRME Metrics
BasicAdvanced
$158M
-
-$1.65
1.85
-
Price and volume
Market cap
$158M
Beta
1.85
52-week high
$2.68
52-week low
$1.12
Average daily volume
1.6M
Financial strength
Current ratio
5.582
Quick ratio
5.017
Long term debt to equity
24.277
Total debt to equity
26.637
Management effectiveness
Return on assets (TTM)
-51.51%
Return on equity (TTM)
-136.88%
Valuation
Price to revenue (TTM)
49.302
Price to book
1.03
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
-1.13
Growth
Earnings per share change (TTM)
-24.17%
3-year earnings per share growth (CAGR)
-51.18%
PRME News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Prime Medicine, Inc. stock?
Prime Medicine, Inc. (PRME) has a market cap of $158M as of April 20, 2025.
What is the P/E ratio for Prime Medicine, Inc. stock?
The price to earnings (P/E) ratio for Prime Medicine, Inc. (PRME) stock is 0 as of April 20, 2025.
Does Prime Medicine, Inc. stock pay dividends?
No, Prime Medicine, Inc. (PRME) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next Prime Medicine, Inc. dividend payment date?
Prime Medicine, Inc. (PRME) stock does not pay dividends to its shareholders.
What is the beta indicator for Prime Medicine, Inc.?
Prime Medicine, Inc. (PRME) has a beta rating of 1.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.